Nomura Asset Management International’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Nomura Asset Management International's VRTX Position: Q2 2026 in Review
Nomura Asset Management International increased its Vertex Pharmaceuticals (VRTX) stake by 2% in Q2 2026, buying an estimated $1.36M and bringing the position to 159,549 shares worth $79.3M. The position accounts for 0.12% of the portfolio, ranked #216.
Nomura Asset Management International first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $80.9M in Q4 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Nomura Asset Management International held 159,549 shares of Vertex Pharmaceuticals worth $79.3M as of Q2 2026.
- Nomura Asset Management International bought 3,065 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.36M.
- Vertex Pharmaceuticals made up 0.12% of Nomura Asset Management International's portfolio in Q2 2026, its #216 holding.
- Nomura Asset Management International first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- Nomura Asset Management International's Vertex Pharmaceuticals position peaked at $80.9M in Q4 2025.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.